MedPath

Shanghai Renji Hospital,Shanghai Jiaotong University,School of Medicine

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma

Not Applicable
Completed
Conditions
Hepatocellular Carcinoma
Molecular Targeted Therapy
Interventions
First Posted Date
2020-11-24
Last Posted Date
2023-08-01
Lead Sponsor
RenJi Hospital
Target Recruit Count
30
Registration Number
NCT04642547
Locations
🇨🇳

Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, Shanghai, China

Melatonin and Risk Of Cardiovascular Events And Malignant Tumors In The Elderly

Not Applicable
Not yet recruiting
Conditions
Cardiovascular Diseases
Interventions
Dietary Supplement: Melatonin
First Posted Date
2020-11-17
Last Posted Date
2020-11-17
Lead Sponsor
RenJi Hospital
Target Recruit Count
10000
Registration Number
NCT04631341

The Effect of Antiemetics on Bowel Preparation Before Colonoscopy

Phase 4
Conditions
Bowel Preparation
Interventions
First Posted Date
2020-10-12
Last Posted Date
2020-10-12
Lead Sponsor
RenJi Hospital
Target Recruit Count
200
Registration Number
NCT04583111
Locations
🇨🇳

Shengliang Chen, Shanghai, China

Treatment of Pregnancy RA

Not Applicable
Conditions
Rheumatoid Arthritis
Pregnancy Related
Interventions
First Posted Date
2020-09-30
Last Posted Date
2020-10-01
Lead Sponsor
RenJi Hospital
Target Recruit Count
100
Registration Number
NCT04569890
Locations
🇨🇳

Renji Hospital, Shanghai, Shanghai, China

Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis

Phase 2
Conditions
Rheumatoid Arthritis
Interventions
Drug: Placebo
First Posted Date
2020-09-02
Last Posted Date
2020-09-02
Lead Sponsor
RenJi Hospital
Target Recruit Count
144
Registration Number
NCT04535427
Locations
🇨🇳

Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension

Phase 1
Conditions
Pulmonary Arterial Hypertension
Interventions
Drug: Sulfasalazine's placebo
Drug: Ambrisentan's placebo
First Posted Date
2020-08-27
Last Posted Date
2020-08-27
Lead Sponsor
RenJi Hospital
Target Recruit Count
80
Registration Number
NCT04528056
Locations
🇨🇳

Renji Hospital, Shanghai, China

Immunotherapy for Elderly Patients With Chronic Osteoporotic Pain

Phase 4
Conditions
Osteoporotic Pain
Interventions
First Posted Date
2020-08-24
Last Posted Date
2020-08-26
Lead Sponsor
RenJi Hospital
Target Recruit Count
100
Registration Number
NCT04524169
Locations
🇨🇳

Diansan Su, Shanghai, Shanghai, China

Intraoperative Cerebral and Renal Tissue Oxygen Saturation and Pediatric Living Donor Liver Transplantation Prognosis.

Recruiting
Conditions
Postoperative Complications
Socioemotional Delay
Developmental Delay
Pediatric Liver Transplantation
First Posted Date
2020-08-19
Last Posted Date
2021-10-04
Lead Sponsor
RenJi Hospital
Target Recruit Count
123
Registration Number
NCT04518332
Locations
🇨🇳

Renji Hospital, Pudong, Shanghai, China

Shanghai Community Cohort Establishment and Follow-up

Recruiting
Conditions
Cardiovascular Diseases
First Posted Date
2020-08-18
Last Posted Date
2023-07-11
Lead Sponsor
RenJi Hospital
Target Recruit Count
80000
Registration Number
NCT04517513
Locations
🇨🇳

Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China

Effects of Post-Operative Sedation for Endovascular Thrombectomy

Not Applicable
Recruiting
Conditions
Endovascular Thrombectomy
Acute Ischemic Stroke
Interventions
Procedure: post-operative sedation
Procedure: routine recovery
First Posted Date
2020-08-18
Last Posted Date
2024-07-03
Lead Sponsor
RenJi Hospital
Target Recruit Count
1286
Registration Number
NCT04517383
Locations
🇨🇳

Renji Hospital, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath